Related Experiment Video
Updated: Jun 12, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue
Jun R Chiong1, Rebecca J Cheung
1Department of Medicine, Cardiology Division, Loma Linda University School of Medicine, Loma Linda, California 92354, USA. jchiong@llu.edu
Insights
Loop diuretics offer symptomatic relief for acute decompensated heart failure (ADHF) but do not improve long-term mortality. High doses of these diuretics may lead to adverse effects, including worsened kidney function.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure (HF) is a prevalent condition with significant healthcare costs, morbidity, and mortality.
- Current treatments for acute decompensated heart failure (ADHF) have yielded neutral results, positioning loop diuretics as a primary therapy.
Purpose of the Study:
- To review the existing evidence on the risks and benefits of loop diuretics in the management of ADHF.
- To evaluate the association between loop diuretic use and patient outcomes in ADHF.
Main Methods:
- A comprehensive literature search of MEDLINE was conducted.
- Articles focusing on heart failure and loop diuretics were identified and reviewed.
Main Results:
- Loop diuretics provide symptomatic improvements, including reduced congestion, increased urine output, and weight loss.
- No long-term mortality benefit has been demonstrated with loop diuretic use.
- High doses of loop diuretics are linked to negative outcomes, such as impaired renal function.
Conclusions:
- Loop diuretics remain valuable in HF management.
- Further well-designed prospective studies are necessary to fully understand the risk-benefit profile of loop diuretics in ADHF.
Background:
Heart failure (HF) is a common condition associated with substantial cost, morbidity, and mortality. Because results of clinical trials in the acute decompensated heart failure (ADHF) setting have been mostly neutral, loop diuretics remain the mainstay of treatment.
Hypothesis:
Loop diuretic use may be associated with unfavorable outcomes.
Methods:
A MEDLINE literature search was performed to identify articles relating to heart failure and loop diuretics. The current evidence on the risks and benefits of loop diuretics for the treatment of ADHF is reviewed.
Results:
Loop diuretics are associated with symptomatic improvements in congestion, urine output, and body weight, but have shown no long-term mortality benefit. Loop diuretics, especially at high doses, are associated with worsened renal function and other poor outcomes.
Conclusions:
Loop diuretics still prove useful in HF treatment, but risk-benefit analysis of these agents in the treatment of ADHF requires a well-designed prospective study.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Mitral Regurgitation IV: Nursing Management
Antihypertensive Drugs: Action of Diuretics